Study: How Effective Is Erenumab in Preventing Migraine?
A new study shows that erenumab is helpful in treating headaches and migraine in patients by blocking a certain protein in the body.
A new study shows that erenumab is helpful in treating headaches and migraine in patients by blocking a certain protein in the body.
Atogepant, a prospective drug currently being developed by AbbVie, lowered migraine days in a recent study and showed optimistic results.
A new study published in The Journal of Headache and Pain has aimed to examine the relationship between headaches and COVID-19.
New research has explored a possible link between type 2 diabetes and migraine - what implications might this have?